427 related articles for article (PubMed ID: 28378930)
21. Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.
Duparc T; Plovier H; Marrachelli VG; Van Hul M; Essaghir A; Ståhlman M; Matamoros S; Geurts L; Pardo-Tendero MM; Druart C; Delzenne NM; Demoulin JB; van der Merwe SW; van Pelt J; Bäckhed F; Monleon D; Everard A; Cani PD
Gut; 2017 Apr; 66(4):620-632. PubMed ID: 27196572
[TBL] [Abstract][Full Text] [Related]
22. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.
Cariou B; van Harmelen K; Duran-Sandoval D; van Dijk TH; Grefhorst A; Abdelkarim M; Caron S; Torpier G; Fruchart JC; Gonzalez FJ; Kuipers F; Staels B
J Biol Chem; 2006 Apr; 281(16):11039-49. PubMed ID: 16446356
[TBL] [Abstract][Full Text] [Related]
23. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
[TBL] [Abstract][Full Text] [Related]
24. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
[TBL] [Abstract][Full Text] [Related]
25. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
[TBL] [Abstract][Full Text] [Related]
26. Orphan receptor small heterodimer partner is an important mediator of glucose homeostasis.
Wang L; Huang J; Saha P; Kulkarni RN; Hu M; Kim Y; Park K; Chan L; Rajan AS; Lee I; Moore DD
Mol Endocrinol; 2006 Nov; 20(11):2671-81. PubMed ID: 16803864
[TBL] [Abstract][Full Text] [Related]
27. Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice.
Massafra V; Milona A; Vos HR; Ramos RJJ; Gerrits J; Willemsen ECL; Ramos Pittol JM; Ijssennagger N; Houweling M; Prinsen HCMT; Verhoeven-Duif NM; Burgering BMT; van Mil SWC
Gastroenterology; 2017 May; 152(6):1462-1476.e10. PubMed ID: 28130067
[TBL] [Abstract][Full Text] [Related]
28. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.
Watanabe M; Houten SM; Mataki C; Christoffolete MA; Kim BW; Sato H; Messaddeq N; Harney JW; Ezaki O; Kodama T; Schoonjans K; Bianco AC; Auwerx J
Nature; 2006 Jan; 439(7075):484-9. PubMed ID: 16400329
[TBL] [Abstract][Full Text] [Related]
29. Bile acids as regulators of hepatic lipid and glucose metabolism.
Trauner M; Claudel T; Fickert P; Moustafa T; Wagner M
Dig Dis; 2010; 28(1):220-4. PubMed ID: 20460915
[TBL] [Abstract][Full Text] [Related]
30. Transgenic mice lacking FGF15/19-SHP phosphorylation display altered bile acids and gut bacteria, promoting nonalcoholic fatty liver disease.
Kim YC; Qi M; Dong X; Seok S; Sun H; Kemper B; Fu T; Kemper JK
J Biol Chem; 2023 Aug; 299(8):104946. PubMed ID: 37348559
[TBL] [Abstract][Full Text] [Related]
31. Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice.
Liu X; Guo GL; Kong B; Hilburn DB; Hubchak SC; Park S; LeCuyer B; Hsieh A; Wang L; Fang D; Green RM
Hepatology; 2018 Jul; 68(1):304-316. PubMed ID: 29377207
[TBL] [Abstract][Full Text] [Related]
32. G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.
Donepudi AC; Boehme S; Li F; Chiang JY
Hepatology; 2017 Mar; 65(3):813-827. PubMed ID: 27351453
[TBL] [Abstract][Full Text] [Related]
33. Microbiota-induced obesity requires farnesoid X receptor.
Parséus A; Sommer N; Sommer F; Caesar R; Molinaro A; Ståhlman M; Greiner TU; Perkins R; Bäckhed F
Gut; 2017 Mar; 66(3):429-437. PubMed ID: 26740296
[TBL] [Abstract][Full Text] [Related]
34. Ablation of IFNγ in myeloid cells suppresses liver inflammation and fibrogenesis in mice with hepatic small heterodimer partner (SHP) deletion.
Zhu L; Litts B; Wang Y; Rein JA; Atzrodt CL; Chinnarasu S; An J; Thorson AS; Xu Y; Stafford JM
Mol Metab; 2024 May; 83():101932. PubMed ID: 38589002
[TBL] [Abstract][Full Text] [Related]
35. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis.
Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P
J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427
[TBL] [Abstract][Full Text] [Related]
36. Nuclear receptors FXR and SHP regulate protein N-glycan modifications in the liver.
Mathur B; Shajahan A; Arif W; Chen Q; Hand NJ; Abramowitz LK; Schoonjans K; Rader DJ; Kalsotra A; Hanover JA; Azadi P; Anakk S
Sci Adv; 2021 Apr; 7(17):. PubMed ID: 33883138
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid.
Ijssennagger N; Janssen AWF; Milona A; Ramos Pittol JM; Hollman DAA; Mokry M; Betzel B; Berends FJ; Janssen IM; van Mil SWC; Kersten S
J Hepatol; 2016 May; 64(5):1158-1166. PubMed ID: 26812075
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of nuclear receptor SHP in adipose tissues affects diet-induced obesity and adaptive thermogenesis.
Tabbi-Anneni I; Cooksey R; Gunda V; Liu S; Mueller A; Song G; McClain DA; Wang L
Am J Physiol Endocrinol Metab; 2010 May; 298(5):E961-70. PubMed ID: 20124506
[TBL] [Abstract][Full Text] [Related]
39. The p300 acetylase is critical for ligand-activated farnesoid X receptor (FXR) induction of SHP.
Fang S; Tsang S; Jones R; Ponugoti B; Yoon H; Wu SY; Chiang CM; Willson TM; Kemper JK
J Biol Chem; 2008 Dec; 283(50):35086-95. PubMed ID: 18842595
[TBL] [Abstract][Full Text] [Related]
40. The orphan nuclear receptor small heterodimer partner is required for thiazolidinedione effects in leptin-deficient mice.
Tseng HT; Park YJ; Lee YK; Moore DD
J Biomed Sci; 2015 May; 22(1):30. PubMed ID: 25951943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
